bevacizumab,pembrolizumab
roche,merck
['gyn', 'beva', 'bevacizumab', 'pembro']
overall survival was also consistent across subgroups of pts w #cervicalcancer treated with pembrolizumab/bevacizumab/chemotherapy cisplatin had higher median survival estimates as compared to carboplatin pts treated with bevacizumab had improved os
#asco22 #gyncsm 
Gyn Onc at MD Anderson. She/Hers. Wife of @DrJasonWestin. Innovative clinical trials. #JCO social media editor. Opinions=mine.
https://t.co/QLXLDKSThc